-
Je něco špatně v tomto záznamu ?
The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro
LT. Nguyen, Z. Myslivečková, B. Szotáková, A. Špičáková, K. Lněničková, M. Ambrož, V. Kubíček, K. Krasulová, P. Anzenbacher, L. Skálová,
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
- MeSH
- antiflogistika nesteroidní chemie metabolismus MeSH
- cytochrom P-450 CYP1A2 chemie metabolismus MeSH
- cytochrom P-450 CYP3A chemie metabolismus MeSH
- inhibiční koncentrace 50 MeSH
- jaterní mikrozomy enzymologie MeSH
- játra enzymologie MeSH
- kinetika MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- potkani Wistar MeSH
- seskviterpeny chemie metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Sesquiterpenes, the main components of plant essential oils, are often taken in the form of folk medicines and dietary supplements. Several sesquiterpenes possess interesting biological activities but they could interact with concurrently administered drugs via inhibition of drug-metabolizing enzymes. Therefore, the present study was designed to test the potential inhibitory effect of tree structurally relative sesquiterpenes β-caryophyllene (CAR), β-caryophyllene oxide (CAO) and α-humulene (HUM) on the activities of the main drug-metabolizing enzymes. For this purpose, rat and human hepatic subcellular fractions were incubated with CAR, CAO or HUM together with specific substrates for oxidation, reduction and conjugation enzymes and their coenzymes. HPLC, spectrophotometric and spectrofluorimetric analyses of product formations were used. All tested sesquiterpenes significantly inhibited cytochromes P4503A (CYP3A) activities in rats as well as in human hepatic microsomes, with CAO being the strongest inhibitor. A non-competitive type of inhibition was found. On the other hand, none of the tested sesquiterpenes significantly affected the activities of carbonyl-reducing enzymes (CBR1, AKRs, NQO1) or conjugation enzymes (UGTs, GSTs, SULTs, COMT). As CYP3A enzymes metabolize many drugs, their inhibition by CAO, CAR and HUM might affect the pharmacokinetics of concurrently administered drugs. Similar results obtained in rat and human hepatic microsomes indicate that rats could be used for further testing of possible drug-sesquiterpenes interactions in vivo.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016256
- 003
- CZ-PrNML
- 005
- 20180521110525.0
- 007
- ta
- 008
- 180515s2017 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2017.10.021 $2 doi
- 035 __
- $a (PubMed)29074051
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Nguyen, Linh Thuy $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: nguyenli@faf.cuni.cz.
- 245 14
- $a The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro / $c LT. Nguyen, Z. Myslivečková, B. Szotáková, A. Špičáková, K. Lněničková, M. Ambrož, V. Kubíček, K. Krasulová, P. Anzenbacher, L. Skálová,
- 520 9_
- $a Sesquiterpenes, the main components of plant essential oils, are often taken in the form of folk medicines and dietary supplements. Several sesquiterpenes possess interesting biological activities but they could interact with concurrently administered drugs via inhibition of drug-metabolizing enzymes. Therefore, the present study was designed to test the potential inhibitory effect of tree structurally relative sesquiterpenes β-caryophyllene (CAR), β-caryophyllene oxide (CAO) and α-humulene (HUM) on the activities of the main drug-metabolizing enzymes. For this purpose, rat and human hepatic subcellular fractions were incubated with CAR, CAO or HUM together with specific substrates for oxidation, reduction and conjugation enzymes and their coenzymes. HPLC, spectrophotometric and spectrofluorimetric analyses of product formations were used. All tested sesquiterpenes significantly inhibited cytochromes P4503A (CYP3A) activities in rats as well as in human hepatic microsomes, with CAO being the strongest inhibitor. A non-competitive type of inhibition was found. On the other hand, none of the tested sesquiterpenes significantly affected the activities of carbonyl-reducing enzymes (CBR1, AKRs, NQO1) or conjugation enzymes (UGTs, GSTs, SULTs, COMT). As CYP3A enzymes metabolize many drugs, their inhibition by CAO, CAR and HUM might affect the pharmacokinetics of concurrently administered drugs. Similar results obtained in rat and human hepatic microsomes indicate that rats could be used for further testing of possible drug-sesquiterpenes interactions in vivo.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika nesteroidní $x chemie $x metabolismus $7 D000894
- 650 _2
- $a cytochrom P-450 CYP1A2 $x chemie $x metabolismus $7 D019388
- 650 _2
- $a cytochrom P-450 CYP3A $x chemie $x metabolismus $7 D051544
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a játra $x enzymologie $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x enzymologie $7 D008862
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a seskviterpeny $x chemie $x metabolismus $7 D012717
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Myslivečková, Zuzana $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: zuzka.mysliveckova@seznam.cz.
- 700 1_
- $a Szotáková, Barbora $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: szotako@faf.cuni.cz.
- 700 1_
- $a Špičáková, Alena $u Department of Pharmacology and Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacky University, Hněvotínská 3, 77515 Olomouc, Czech Republic. Electronic address: alena.spicakova@upol.cz.
- 700 1_
- $a Lněničková, Kateřina $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: lnenickk@faf.cuni.cz.
- 700 1_
- $a Ambrož, Martin $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: ambrozm@faf.cuni.cz.
- 700 1_
- $a Kubíček, Vladimír $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: kubicek@faf.cuni.cz.
- 700 1_
- $a Krasulová, Kristýna $u Department of Pharmacology and Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacky University, Hněvotínská 3, 77515 Olomouc, Czech Republic. Electronic address: Kkrasulova@seznam.cz.
- 700 1_
- $a Anzenbacher, Pavel $u Department of Pharmacology and Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacky University, Hněvotínská 3, 77515 Olomouc, Czech Republic. Electronic address: anzen@seznam.cz.
- 700 1_
- $a Skálová, Lenka $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic. Electronic address: lenka.skalova@faf.cuni.cz.
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 278, č. - (2017), s. 123-128
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29074051 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180521110707 $b ABA008
- 999 __
- $a ok $b bmc $g 1299880 $s 1013096
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 278 $c - $d 123-128 $e 20171023 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20180515